Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Alzheimer's Disease, Art and Garden [NA]
This document provides an update on an Alzheimer's disease clinical trial conducted by Central Hospital in Nancy, France. The current status…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) [Phase 2]
A Phase 2 trial of MK0677 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: A Study to Evaluate the Use of an Indwelling Catheter to Obtain Cerebrospinal Fluid (CSF) by Low-rate Continuous Sampling (MK-0000-211)
This update reports the completion of a clinical trial evaluating a low-rate, continuous sampling indwelling catheter to obtain cerebrospina…
-
FDA approval · 2015-07-22FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA granted supplemental approval for a generic rivastigmine tartrate product from Dr. Reddy's Laboratories Limited (ANDA 077130).
-
FDA approval · 2015-07-20FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-07-20FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) from Eisai Inc.
-
FDA approval · 2015-07-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approves a supplemental application for donepezil hydrochloride from Dr. Reddys Laboratories Limited. Donepezil is a treatment for Alzhe…
-
FDA approval · 2015-07-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride from Torrent Pharmaceuticals Limited, authorizing changes to its labelin…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: Memory and Insulin in Early Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating memory and insulin approaches in early Alzheimer's disease. The study is completed, with results posted …
-
FDA approval · 2015-07-09FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (Florbetapir F-18) by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: The Feasibility of Florbetapir Quantitation in Europe [Phase 4]
Phase 4 study evaluating the feasibility of quantifying florbetapir in Europe for Alzheimer's disease; results were posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-06-26Clinical Trial Update: Reminiscence, Anxiety and Early Alzheimer's Disease [NA]
Clinical trial investigating reminiscence and anxiety in early Alzheimer's disease has been withdrawn.
-
FDA approval · 2015-06-25FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for AMYVID (Florbetapir F 18) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease [Phase 1]
Phase 1 study evaluating JNJ-54861911 on amyloid-beta processing in cerebrospinal fluid and plasma in prodromal Alzheimer's disease has comp…
-
FDA approval · 2015-06-24FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc, indicating an approved change related to this drug. The ac…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to Risperidone [Phase 4]
A Phase 4 trial comparing escitalopram to risperidone for behavioral and psychological symptoms in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006 [Phase 2]
A Phase 2 follow-up study evaluating continued AFFITOPE AD02 vaccinations in Alzheimer's disease participants has been terminated.
-
FDA approval · 2015-06-23FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute)
FDA approved the original application for Fludeoxyglucose F-18 as a radiopharmaceutical imaging agent for PET scans, developed by the Univer…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: CATIE-Alzheimer's Disease Trial [NA]
This entry notes that the CATIE-AD Alzheimer's trial sponsored by the National Institute of Mental Health has completed.
-
CLINICAL_TRIALS research · 2015-06-12Clinical Trial Update: Alzheimer's Disease Core Center
Clinical Trial Update describing the University of Arizona's Alzheimer's Disease Core Center trial. The conditions listed are Alzheimer's di…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease [Phase 1]
This Phase 1 randomized, double-blind, placebo-controlled study evaluated safety, tolerability, pharmacokinetics, immunogenicity, and pharma…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) [Phase 1]
A Phase 1 trial evaluating MK-0249 with an Alzheimer's disease medication in adults with Alzheimer’s disease and dementia was terminated; re…
-
FDA approval · 2015-06-05FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original generic application for donepezil hydrochloride, making a generic version of the Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD) [Phase 2]
A Phase 2 study of AZD3480 in mild to moderate Alzheimer's disease has completed. The trial evaluated efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: The Feasibility of Florbetapir Quantitation [Phase 4]
A Phase 4 trial update assessing the feasibility of quantifying florbetapir for PET imaging in Alzheimer's disease.